Nanoliposomes as Potential New Stroke Treatment
November 17, 2021
Stroke remains a leading cause of death and disability among veterans and the general public
A Novel Molecular First Responder Could Improve Patient Outcomes after Heart Attack or Stroke
June 16, 2021
Dr. Glembotski and his team of research scientists may revolutionize the treatment of cardiovascular diseases
Christopher Glembotski, PhD
Monday, December 14, 2020
Dr. Glembotski hopes to identify the molecules of the heart that cause heart disease, mitigating their effects
Researchers Awarded $8 Million Grant to Study Depression and Cardiovascular Disease
November 30, 2020
Grant to better understand co-occurrence of major depression and heart disease
Zhiyu Dai, PhD
Tuesday, December 15, 2020
Dr. Dai's research focuses on cardiovascular disease, specifically pulmonary hypertension